Literature DB >> 1509256

Tuberculosis: commentary on a reemergent killer.

B R Bloom1, C J Murray.   

Abstract

Tuberculosis remains the leading cause of death in the world from a single infectious disease, although there is little knowledge of the mechanisms of its pathogenesis and protection from it. After a century of decline in the United States, tuberculosis is increasing, and strains resistant to multiple antibiotics have emerged. This excess of cases is attributable to changes in the social structure in cities, the human immunodeficiency virus epidemic, and a failure in certain major cities to improve public treatment programs. The economic costs of not adequately addressing the problem of tuberculosis in this country are estimated from an epidemiological model.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1509256     DOI: 10.1126/science.257.5073.1055

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  323 in total

1.  Boosting vaccine for tuberculosis.

Authors:  J V Brooks; A A Frank; M A Keen; J T Bellisle; I M Orme
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Functional domains present in the mycobacterial hemagglutinin, HBHA.

Authors:  G Delogu; M J Brennan
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

3.  A novel approach to directly observed therapy for tuberculosis in an HIV-endemic area.

Authors:  M Desvarieux; P R Hyppolite; W D Johnson; J W Pape
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 4.  Tuberculosis: 3. Epidemiology of the disease in Canada.

Authors:  R Long; H Njoo; E Hershfield
Journal:  CMAJ       Date:  1999-04-20       Impact factor: 8.262

5.  Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination.

Authors:  S Sreevatsan; X Pan; K E Stockbauer; N D Connell; B N Kreiswirth; T S Whittam; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

6.  Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.

Authors:  B Phetsuksiri; A R Baulard; A M Cooper; D E Minnikin; J D Douglas; G S Besra; P J Brennan
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

7.  Recent Developments in Epidemiology, Treatment, and Diagnosis of Tuberculosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

8.  Top down characterization of secreted proteins from Mycobacterium tuberculosis by electron capture dissociation mass spectrometry.

Authors:  Ying Ge; Mariam El-Naggar; Siu Kwan Sze; Han Bin Oh; Tadhg P Begley; Fred W McLafferty; Helena Boshoff; Clifton E Barry
Journal:  J Am Soc Mass Spectrom       Date:  2003-03       Impact factor: 3.109

Review 9.  Potential role of cytokines in disseminated mycobacterial infections.

Authors:  L E Bermudez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

10.  Confronting "hereditary" disease: eugenic attempts to eliminate tuberculosis in progressive era America.

Authors:  Philip K Wilson
Journal:  J Med Humanit       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.